Plant-Based Magnesium Composition for CNS Absorption

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Existing magnesium supplements have limited absorption rates, making it difficult to effectively address magnesium deficiencies, which are associated with cardiovascular disease, osteoporosis, and metabolic disorders like hypertension and type 2 diabetes mellitus, and there is a need for compositions and methods to improve magnesium delivery and absorption, particularly into the cerebrospinal fluid.

Innovation Solution

A composition comprising a combination of pseudograins and leafy vegetables, such as Buckwheat and Swiss Chard, in a specific ratio, which enhances magnesium bioavailability and delivery, including into the cerebrospinal fluid, providing a natural source of magnesium with improved absorption compared to salt forms.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Quantity of substance

If traditional magnesium supplements are used, then magnesium intake is increased, but absorption rate remains limited (20-50%)

Engineering Contradiction:
Improvemagnesium intakeVSAvoidabsorption rate
Core Design Contradiction:
Quantity of substanceVSReliability

Solution Approach 1:

The patent changes the chemical form of magnesium from traditional salt forms to plant-based forms (pseudograins and leafy vegetables), which fundamentally alters the absorption parameters. This parameter change enables the magnesium to bypass the 20-50% absorption limitation of traditional supplements and achieve superior delivery to the cerebrospinal fluid and brain tissues.

Inventive Principle:
Principle #35Parameter changes

Solution Approach 2:

The invention uses composite plant-based materials combining pseudograins and leafy vegetables as magnesium sources. This composite approach leverages the synergistic effects of different plant matrices, which together provide enhanced bioavailability and absorption compared to single-source supplements or traditional inorganic magnesium salts.

Inventive Principle:
Principle #40Composite materials

2Quantity of substance

If magnesium supplements are taken to address deficiencies, then serum magnesium levels may increase, but delivery to cerebrospinal fluid and brain remains insufficient

Engineering Contradiction:
Improvemagnesium levelsVSAvoiddelivery efficiency
Core Design Contradiction:
Quantity of substanceVSEase of operation

Solution Approach 1:

The plant-based magnesium compounds act as intermediaries that facilitate transport across the blood-brain barrier. These plant matrices serve as mediators that enable magnesium to cross biological barriers that traditional supplements cannot, thereby improving delivery efficiency to the cerebrospinal fluid and brain tissues.

Inventive Principle:
Principle #24Intermediary (Mediator)

3Reliability

If conventional magnesium supplements are used, then magnesium deficiency symptoms may be addressed, but side effects like constipation occur

Engineering Contradiction:
Improvedeficiency correctionVSAvoidside effects
Core Design Contradiction:
ReliabilityVSObject-generated harmful factors

Solution Approach 1:

The patent employs natural, transient plant-based materials that are fully metabolizable and do not accumulate in the body like inorganic supplements. These plant matrices are naturally degraded and eliminated, providing magnesium correction without the persistent harmful effects such as constipation associated with traditional supplements.

Inventive Principle:
Principle #27Cheap short-living objects (Disposable)

Data Source

PatentUS12564605B2Plant based compositions and methods for the delivery of magnesium
Publication Date: 2026.03.03 STANDARD PROCESS INC
  • US12564605B2 patent drawing
  • US12564605B2 patent drawing
  • US12564605B2 patent drawing

AI summary

The disclosure relates to compositions and methods for delivery of magnesium. In one embodiment, the disclosure relates to a composition comprising a first plant based source of magnesium and a second plant based source of magnesium. In on embodiment, the disclosure relates to methods for delivering magnesium to the central nervous system of an individual.